ISSN : 3023-7505
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Automated Perimetry
Carbonic Anhydrase Inhibitors
Intra Ocular Lens Power Calculation and Optic Biometry...
Visual Field Defects in Glaucoma
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
Current Minimal Invasive Angle Procedures Without Implants for the Treatment of Glaucoma...
Intra Ocular Lens Power Calculation and Optic Biometry...
Automated Perimetry
Carbonic Anhydrase Inhibitors
Visual Field Defect and Retinal Nerve Fiber Layer Defect in a Case of Optic Nerve Head Drusen...
PureSee Kesintisiz Yüksek Kalitede Görüş
TJ-CEO 2006 , Vol 1 , Num 2
Turkish Abstract Abstract PDF Similar Articles Mail to Author
Ocular Hypotensive Lipids
Zeynep ÖZBEK1, Gül ARIKAN1, Aylin YAMAN1, İsmet DURAK1
Dokuz Eylül Üniversitesi Tıp Fakültesi, Göz Hastalıkları A.D., İzmir A new group of drugs very similar to prostaglandins in structure, namely ocular hypotensıve lipids have recently gained popularity in the current medical treatment of glaucoma. Ocular hypotensive lipids include prostagtandin analogues and prostamides. Prostaglandin analogues are derivatives of prostaglandin F2α. They increase uveoscleral outflow and can decrease the intraocular pressure up to 50%. The prostaglandin analogues used in current glaucoma therapy are latanoprost, unoprostone and travoprost. The only prostamide is bimatoprost. These drugs not only have similar structure and mechanism of action but also cause similar side effects. They provide similar decreases in the intraocular pressure except for unoprostone. Conjunctival hyperemia, periocular skin color changes, increase in the number and length of lashes are frequently reported. Cystoid macular edema and activation of herpetic keratitis are some serious side effects encountered in selected patients. Keywords : Glaucoma, prostaglandin analogues, ocular hypotensive lipids
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact